ROCHESTER GENERAL HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.3M
- Transactions
- 418
- Companies
- 40
- Average per transaction
- $7,938
Who reported the payments
| Merck | $964,138 |
| Shire North American Group Inc | $369,551 |
| Edwards Lifesciences | $315,967 |
| CSL Behring | $202,681 |
| Regeneron | $194,032 |
| Kyowa Kirin Pharmaceutical Development, Inc | $191,882 |
| Medtronic | $135,006 |
| Roche Products Limited | $129,963 |
| Boston Scientific | $110,202 |
| Ortho-clinical Diagnostics, Inc. | $79,946 |
| Takeda Pharmaceuticals U.S.A., Inc. | $77,235 |
| Abbott | $62,199 |
| Biosense Webster, Inc. | $59,100 |
| Pentax Of America, Inc. | $56,986 |
| Amgen | $38,282 |
| Bard Peripheral Vascular, Inc. | $35,363 |
| Biofire Diagnostics, LLC | $29,935 |
| Pfizer | $28,006 |
| Sanofi US Services Inc. | $27,762 |
| Olympus America Inc. | $21,650 |
| Aesculap, Inc. | $21,257 |
| Jazz Pharmaceuticals Inc. | $16,833 |
| Smith+Nephew | $14,701 |
| Tandem Diabetes Care, Inc. | $14,400 |
| Stryker | $13,686 |
| Incyte Corporation | $13,521 |
| Biotronik Inc. | $13,435 |
| Novartis | $10,323 |
| Bristol Myers Squibb | $10,100 |
| Cumberland Pharmaceuticals, Inc. | $8,790 |
| Siemens Medical Solutions USA, Inc. | $8,356 |
| Mckesson Corporation | $8,000 |
| Zimmer Biomet | $6,010 |
| Daiichi Sankyo Inc. | $4,150 |
| Johnson & Johnson | $4,026 |
| GE HealthCare | $3,844 |
| AstraZeneca | $2,500 |
| Angiodynamics, Inc. | $2,360 |
| Barco, Inc. | $2,266 |
| E.r. Squibb & Sons, L.L.C. | $2,000 |